Follow the 신흥 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 신흥 has logged 148 public disclosures. Market capitalisation: €130bn. The latest transaction was filed on 29 May 2026 (Purchase). Among the most active insiders: 이용익. Every trade is free.
141
Insider Decl.
n/a
Thresholds
€639,089
22 ops.
Buy Volume
€397,056
48 ops.
Sell Volume
30Σ signal
Buys €639,089€397,056 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 18,928 of 29,064 companies
42.1
score / 100
Value
38
Quality
46
FCF yld-1.2%
Earn yld2.2%
EV/EBITDA15.2x
ROE3.0%
Gross mgn31%
Net mgn2.8%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
신흥 is a company in the healthcare and pharmaceutical sector listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.
